Literature DB >> 15048884

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion.

Michael H Barnett1, John W Prineas.   

Abstract

The study describes the clinical and pathological findings in 12 patients with relapsing and remitting multiple sclerosis, who died during or shortly after the onset of a relapse. Pathological changes not previously associated with the formation of new symptomatic lesions were observed in seven cases, namely, extensive oligodendrocyte apoptosis and microglial activation in myelinated tissue containing few or no lymphocytes or myelin phagocytes. No current laboratory model of multiple sclerosis, in particular, experimental allergic encephalomyelitis, is known with these features, which raises the possibility of some novel process underlying new lesion formation in multiple sclerosis.

Entities:  

Mesh:

Year:  2004        PMID: 15048884     DOI: 10.1002/ana.20016

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  344 in total

Review 1.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

Authors:  Reinhard Hohlfeld; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

Review 2.  Viruses and multiple sclerosis.

Authors:  Gregory P Owens; Don Gilden; Mark P Burgoon; Xiaoli Yu; Jeffrey L Bennett
Journal:  Neuroscientist       Date:  2011-12       Impact factor: 7.519

3.  Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.

Authors:  Andrew J Steelman; Jeffrey P Thompson; Jianrong Li
Journal:  Neurosci Res       Date:  2011-10-12       Impact factor: 3.304

4.  Heterogeneity versus homogeneity of multiple sclerosis.

Authors:  Fumitaka Sato; Nicholas E Martinez; Seiichi Omura; Ikuo Tsunoda
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

5.  Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.

Authors:  Andrew V Caprariello; Saisho Mangla; Robert H Miller; Stephen M Selkirk
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

6.  Fractional anisotropy of white matter, disability and blood iron parameters in multiple sclerosis.

Authors:  Estelle Herbert; Penelope Engel-Hills; Coenraad Hattingh; Jean-Paul Fouche; Martin Kidd; Christine Lochner; Maritha J Kotze; Susan J van Rensburg
Journal:  Metab Brain Dis       Date:  2018-02-02       Impact factor: 3.584

7.  Pathologic heterogeneity persists in early active multiple sclerosis lesions.

Authors:  Imke Metz; Stephen D Weigand; Bogdan F G Popescu; Josa M Frischer; Joseph E Parisi; Yong Guo; Hans Lassmann; Wolfgang Brück; Claudia F Lucchinetti
Journal:  Ann Neurol       Date:  2014-05-13       Impact factor: 10.422

8.  Biochemically altered myelin triggers autoimmune demyelination.

Authors:  Andrew V Caprariello; James A Rogers; Megan L Morgan; Vahid Hoghooghi; Jason R Plemel; Adam Koebel; Shigeki Tsutsui; Jeffrey F Dunn; Lakshmi P Kotra; Shalina S Ousman; V Wee Yong; Peter K Stys
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-04       Impact factor: 11.205

Review 9.  Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence.

Authors:  Mahshid Yeganeh Salehpour; Adriano Mollica; Saeideh Momtaz; Nima Sanadgol; Mohammad Hosein Farzaei
Journal:  Clin Drug Investig       Date:  2019-07       Impact factor: 2.859

10.  Low-density lipoprotein receptor-related protein 1 is an essential receptor for myelin phagocytosis.

Authors:  Alban Gaultier; Xiaohua Wu; Natacha Le Moan; Shinako Takimoto; Gatambwa Mukandala; Katerina Akassoglou; W Marie Campana; Steven L Gonias
Journal:  J Cell Sci       Date:  2009-03-19       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.